Chemical Structure : Cabozantinib
CAS No.: 849217-68-1
Catalog No.: PC-43324Not For Human Use, Lab Use Only.
Cabozantinib (XL184, BMS-907351) is a potent multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $58 | In stock | |
10 mg | $88 | In stock | |
50 mg | $198 | In stock | |
100 mg | $298 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Cabozantinib (XL184, BMS-907351) is a potent multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Cabozantinib (XL184, BMS-907351) eliminates tumor vasculature, reduces pericytes and empty basement membrane sleeves.
Cabozantinib (XL184, BMS-907351) causes widespread intratumoral hypoxia and tumor cell apoptosis, and slows regrowth of the tumor vasculature.
Cabozantinib (XL184, BMS-907351) also decreases invasiveness of primary tumors and reduces metastasis in pancreatic islet cancer.
Cabozantinib (XL184, BMS-907351) exerts marked anti-MPNST effects in vitro and in vivo.
M.Wt | 501.5057 | |
Formula | C28H24FN3O5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 30 mg/mL |
|
Chemical Name/SMILES |
1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)- |
1. You WK, et al. Cancer Res. 2011 Jul 15;71(14):4758-68.
2. Durante C, et al. Expert Opin Investig Drugs. 2011 Mar;20(3):407-413.
3. Torres KE, et al. Clin Cancer Res. 2011 Jun 15;17(12):3943-55.
4. Kurzrock R, et al. J Clin Oncol. 2011 Jul 1;29(19):2660-6.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright